The Three Main Functions of Plasmalogens (C102)

Plasmalogens neutralize peroxides, they modulate membrane structure and the function of membrane proteins, and they modulate the efficiency and ease of vesicular release of neurotransmitters. They are obligate to life.   

To access the FREE seminars with full presentations and videos please visit Dr. Goodenowe’s resource site here. This is the article for seminar C102, Supplements (Series C).

Plasmalogens are a type of glycerophospholipid. Glycerophospholipids are the building material your body uses to make biological walls, or membranes. Your body contains trillions of cells, and each cell is like a suite in a high-rise apartment building. Each unit is separated from the others by a strong outer wall. Also, each cell contains internal compartments called organelles, such as mitochondria or peroxisomes, and these organelles are also separated from each other by membranes. The body compartmentalizes its activities much like we separate our kitchen from our bathroom from our bedroom. Just like in our house, these internal walls are less rigid. All the cells are connected to our circulatory system and all the intracellular organelles are connected to the internal cytoplasm of the cell.  

Many types of glycerophospholipids exist. But they all share common characteristics. They are all built on a glycerol backbone molecule. Think of glycerol as a 3-outlet power strip to which you can connect various attachments. The olive oil in your pantry is a glycerolipid that has the essential omega-9 fatty acid, oleic acid, plugged into each of the three outlets. Olive oil is a triacylglycerol. Glycerophospholipids have a polar phosphate group plugged into the end outlet, called the sn-3 position. This is called the head group. Several types of phosphate head groups exist, but the two main ones are phosphocholine and phosphoethanolamine. The polar head groups like the water part of a cell and are called hydrophilic (the vinegar part of an oil and vinegar dressing). The other two positions contain fatty acids (like olive oil) and they like to associate with the lipid or oily part of the cell and are called lipophilic. The first position, the sn-1 position, contains one of three anchor fatty acids (palmitic, stearic, or oleic). The middle position contains the bioactive fatty acid and is where the body stores most of its omega-3 fatty acids, like DHA. Together the sn-1 and sn-2 positions are called the tails. A glycerophospholipid that does not contain an sn-2 fatty acid is called a lysophospholipid.  

Glycerophospholipids self-organize into membranes by forming a phospholipid bilayer where the lipophilic tails mingle together to form an impermeable oily center, and the polar head groups face out from each other into the aqueous environment. Proteins are embedded in the membrane and they act like doors and vents that allow materials to pass through the membrane and move in and out of the cells and the compartments within the cells. These doors and vents are key coded so that only glucose can go through a glucose door, for example. Each of these proteins is anchored in the membrane; the membrane holds them in place. The fluidity of these membranes is tightly regulated. The yin and yang are cholesterol/phosphatidylcholine (PC) and polyunsaturated fatty acid (PUFA) containing ethanolamine plasmalogens (PLE) and phosphatidylethanolamines (PE). Higher levels of cholesterol and PC result in stiffer, more rigid membranes. Higher levels of PUFA-PLE and PUFA-PE result in more fluid membranes. 

Plasmalogens are a unique type of glycerophospholipid. Plasmalogens have a fatty alcohol at the sn-1 position instead of a fatty acid like other glycerophospholipids. All the building blocks for regular glycerophospholipids can be easily obtained from our diet. However, only minimal amounts of plasmalogens can be obtained from the diet. Plasmalogens are synthesized in a unique organelle called the peroxisome. Virtually all the cells of the body contain peroxisomes. This same organelle also performs the final step in synthetizing the essential long-chain omega-3 fatty acid, docosahexaenoic acid, otherwise known as DHA. The unique physiochemical properties that give plasmalogens their special powers also make them unstable outside the body. When you eat food containing plasmalogens, most of them get degraded by the strongly acidic environment in your stomach before they can be absorbed.  

The unique sn-1 vinyl ether bond in plasmalogens gives them three special powers. The first special power makes them the body’s dominant free radical scavenger. The unique vinyl ether bond is exquisitely sensitive to free radicals and reactive oxygen species, especially peroxides. Your body does not depend on getting plasmalogens from your diet because you can typically make as many of them as you need. Plasmalogens are designed to be sacrificed to protect nutrients that must be obtained from your diet, such as essential omega-3 and omega-6 fatty acids that your body cannot make. Other antioxidants, like vitamin E, are only lipid soluble. So, they only prevent oxidation on the inside of the membrane, but the plasmalogen vinyl ether bond is positioned close to the polar head group so that it is located near the border between the membrane and the aqueous environment. Therefore, plasmalogens are the first line of defense, and internal membrane antioxidants like vitamin E are the last line of defense. 

The second special power of plasmalogens is their membrane modulation effect. Depending on the sn-2 fatty acid, plasmalogens can create either a very tightly packed membrane or a very fluid membrane and everything in-between. For example, all your neurons are encased by a myelin sheath that performs a similar function to the insulating coating that encases an electrical cord in your house. This myelin sheath performs two functions. First, it protects your neurons from being damaged by external oxidative degradation and secondly, it prevents the internal transmission of the nerve impulse from leaking out. A neuron impulse can travel long distances in the body without losing its intensity due to its myelin sheath. Myelin contains the highest concentration of plasmalogens in the body. Approximately 80% of the ethanolamine content of the myelin sheath is plasmalogen, and the vast majority of these plasmalogens contain the monounsaturated omega-9 fatty acid oleic acid at the sn-2 position. In this situation, the plasmalogens create a very solid impervious coating, just like the insulation you have on a regular copper wire. On the opposite side of the spectrum and described in greater detail in Chapter 12, the level of DHA-plasmalogens in cellular membranes modulate the fluidity of the membrane and regulate the functions of proteins embedded in the membrane. Two important examples are the ability of a cell to efflux cholesterol and the ability of a neuron to properly metabolize the amyloid precursor protein (APP).  

The third and final special power of plasmalogens is their ability to form an inverse hexagonal phase. As I introduced in Chapter 3, the formation of this phase is a biophysical process, and it is necessary for neuronal transmission and for the brain to create its quantum computing powers. Your brain can only maintain that activity level if it has sufficient levels of plasmalogens in the synapse to enable the fusion and release of neurotransmitters and sufficient levels of plasmalogens in the myelin sheath to enable signal transmission from one neuron to another. This basic physiological process, common to all neurons in the human brain, is independent of the type of neuron, neurotransmitter, or postsynaptic receptor. Over 100 different presynaptic neurotransmitters have been identified. Most neurons are identified by the type of neurotransmitter used by that neuron. Each type of neuron can communicate with a multiplicity of different types of neurons. Accordingly, each neuron type contains receptors from multiple different types of neurotransmitters. Most neurotransmitters react with many different types of postsynaptic receptors. You can think of neurotransmitters as master keys that can open many different doors and the neurotransmitter receptors as these different doors. These neurotransmitters and their receptors have been the targets of decades of pharmaceutical research which has resulted in a cornucopia of psychoactive agents. All these drugs modify brain neuron action. Depending on the target, they either enhance or inhibit specific neuron activities. None of these drugs affect the basic physiology of the brain. Their activities are dependent upon the basic physiology of the brain being intact. 

At its most fundamental level, the brain is controlled by negative feedback or inhibitory mechanisms. I often tell people to think of the brain as a team of racing horses pulling a wagon and to imagine themselves restraining the horses with a tight hold on the reigns. If you want to turn the horses to the right, all you have to do is slightly release your hold on the left-hand side reins and vice versa. We have such fine motor skills and quick wit because the brain is like a pre-compressed spring, always ready and waiting to be released. Neurological decline affects both the loading or pre-compressing of the spring and the ability to control the spring. Impairments in cognition and mobility happen when the excitatory neuron system (the team of horses or pre-compressed spring) is weakened. This is manifested when normal functioning becomes stilted or lacks its normal smoothness or readiness of function. Mood impairments or uncontrolled motor activity occur when the inhibitory neuron system (the reigns) is weakened. These excitatory and inhibitory systems become increasingly in tune with each other as we develop from infants to children to adults. The human brain does not fully mature until our 50s. By then, the balance in these systems has become the most efficient it will ever be. However, this efficiency comes at the cost of plasticity. It is harder to teach old dogs new tricks, but they are really good at the old ones. 

Reduced cognition is one of the first, most prevalent, and most noticeable functional declines of the human brain. Around age 60, we start to see neuropathological changes in the brain. Accordingly, the neuropathological changes that correlate with and are associated with reduced mental function have been the most studied. 

Dr. Goodenowe explains the relevant research and literature regarding three main biological functions of plasmalogens in seminar C102 – The Three Main Function of Plasmalogens. 

Share on facebook
Share on twitter
Share on linkedin
privacy
Your privacy is important to us.

To better protect your privacy, we provide this notice explaining our online information practices and the choices you can make about the way your information is collected and used. To make this notice easy to find, we make it available on our homepage and at every point where personally identifiable information may be requested.

Collection of Personal Information

When visiting drdayangoodenowe.com, the IP address used to access the site will be logged along with the dates and times of access. This information is purely used to analyze trends, administer the site, track users’ movement and gather broad demographic information for internal use. Most important, any recorded IP addresses are not linked to personally identifiable information.

Links to Third-Party Websites
We have included links on this site for your use and reference. We are not responsible for the privacy policies on these websites. You should be aware that the privacy policies of these sites may differ from our own.
Our Use of Google Analytics
The Dr. Dayan Goodenowe website uses the Google Analytics tool to measure traffic on the site and traffic to the site via our online advertising. This includes using certain Advertising Features, which enable Google Analytics to collect data about users via Google advertising cookies and identifiers, in addition to anonymous data collected through the standard Google Analytics implementation. These Advertising Features, which drdayangoodenowe.com may or may not be currently using, include:
  • Remarketing with Google Analytics. This allows us to display our ads to you as you search online for similar businesses.
  • Google Display Network Impression Reporting, which shows which of our ads users click on.
  • Google Analytics Demographics and Interest Reporting, which provides information about the age and gender of site users, along with the interests they express in their online travel and purchasing activities.
  • Integrated services that require Google Analytics to collect data via advertising cookies and identifiers.
We do not merge personally identifiable information with non-personally identifiable information collected through any Google advertising product or feature unless we have obtained robust notice of, and the user’s prior affirmative (i.e., opt-in) consent to, that merger. These Advertising Features, which drdayangoodenowe.com may or may not be currently using, include:
Opt Out

There are several ways to opt out of interest-based advertising and/or all tracking related to Google Analytics and its advertising features.
You can opt out of interest-based ads by Google through Ads Settings. When you opt out, you’ll still see ads but they may not be related to factors such as your interests, previous visits to other websites, or demographic details. Obtain instructions here.

The Network Advertising Initiative offers a free tool that allows users to opt out from receiving interest-based ads from some or all NAI participating member companies that use cookies on your computer browser to collect data for interest-based advertising. Find information about it here.

Website visitors can totally block Google Analytics with the Google Analytics opt-out browser add-on (click to download). This add-on instructs the Google Analytics JavaScript (ga.js, analytics.js, and dc.js) running on websites to prohibit their information from being used by Google Analytics. Using the Google Analytics opt-out plug-in will not prevent site owners from using other tools to measure site analytics. Learn more about about the opt-out and how to properly install the browser add-on here.

Changes to this Privacy

Statement The contents of this statement may be altered at any time, at our discretion.

If you have any questions regarding the privacy policy of drdayangoodenowe.com then you may contact us at info@drdayangoodenowe.com

terms of use
Welcome to our website. If you continue to browse and use this website, you are agreeing to comply with and be bound by the following terms and conditions of use, which together with our privacy policy govern drdayangoodenowe.com’s relationship with you in relation to this website. If you disagree with any part of these terms and conditions, please do not use our website.

The term ‘drdayangoodenowe.com’ or ‘us’ or ‘we’ refers to the owner of the website whose registered office is:

40880 County Center Drive
Suite R
Temecula, CA 92591, USA

The term ‘you’ refers to the user or viewer of our website.

The use of this website is subject to the following terms of use:

The content of the pages of this website is for your general information and use only. It is subject to change without notice.

Neither we nor any third parties provide any warranty or guarantee as to the accuracy, timeliness, performance, completeness or suitability of the information and materials found or offered on this website for any particular purpose. You acknowledge that such information and materials may contain inaccuracies or errors and we expressly exclude liability for any such inaccuracies or errors to the fullest extent permitted by law.

Your use of any information or materials on this website is entirely at your own risk, for which we shall not be liable. It shall be your own responsibility to ensure that any products, services or information available through this website meet your specific requirements.

This website contains material which is owned by or licensed to us. This material includes, but is not limited to, the design, layout, look, appearance and graphics. Reproduction is prohibited other than in accordance with the copyright notice, which forms part of these terms and conditions.

All trademarks reproduced in this website, which are not the property of, or licensed to the operator, are acknowledged on the website.

Unauthorized use of this website may give rise to a claim for damages and/or be a criminal offence.

From time to time, this website may also include links to other websites. These links are provided for your convenience to provide further information. They do not signify that we endorse the website(s). We have no responsibility for the content of the linked website(s).

Your use of this website and any dispute arising out of such use of the website is subject to the laws of Canada and USA.

We use cookies to make this site as useful as possible. They are small text files we put in your browser to track usage of our site but they don’t tell us who you are. If you want to delete any cookies that are already on your computer, please refer to the instructions for your file management software to locate the file or directory that stores cookies.

This site is not a part of the Facebook website or Facebook Inc. Additionally, this site is not endorsed by Facebook in any way. FACEBOOK is a trademark of FACEBOOK, Inc.